Use of multimedia devices in pediatric age: risks or advantages? A survey in an Italian center

Ilaria Lazzareschi1, Antonietta Curatola2, Sabrina DE Pascalis3

  • 1Department of Pediatrics, IRCCS A. Gemelli University Polyclinic Foundation, Rome, Italy.

Minerva Pediatrics
|June 6, 2024
PubMed

Insights

Children and adolescents face significant risks from multimedia device use. This study highlights the prevalence of device ownership and unsupervised usage, emphasizing the need for education on responsible digital habits.

Area of Science:

  • Pediatrics
  • Digital Health
  • Child Psychology

Background:

  • Modern children are immersed in a digital environment, facing potential health and safety risks.
  • Investigating the usage patterns of multimedia devices among children and adolescents is crucial.

Purpose of the Study:

  • To examine the use of multimedia devices in a sample of children and adolescents.
  • To identify risks associated with digital device usage in young individuals.

Main Methods:

  • Anonymous, age-specific questionnaires were distributed to 500 children/adolescents and 370 parents.
  • Data collection occurred between November 2018 and June 2019 at a University Hospital.

Main Results:

  • 17.1% of children owned a mobile device, with 54.1% using multimedia devices for 30-60 minutes daily.
  • Significant unsupervised usage was reported, with discrepancies between parent and child information.
  • Social media platforms like WhatsApp, Instagram, and Facebook are widely used, often during meals, class, and before sleep, contributing to cyberbullying.

Conclusions:

  • Multimedia device use presents more risks than benefits for children and adolescents.
  • Educating young users on correct and responsible digital device engagement is essential.
Abstract

Related Concept Videos

Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...